387 articles with AmerisourceBergen
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2022 on Wednesday, February 2, 2022 prior to the opening of trading on the New York Stock Exchange.
AmerisourceBergen to Now Offer Prime Therapeutics’ IntegratedRx™ – Oncology to Eligible Hospital, Health System & Oncology Practice Customers
AmerisourceBergen today announced that it is now offering Prime Therapeutics’ IntegratedRx™ – Oncology program to eligible hospital, health system and independent oncology practice customers.
AmerisourceBergen Corporation reported that in its fiscal year 2021 fourth quarter ended September 30, 2021, revenue increased 19.6 percent to $58.9 billion.
AmerisourceBergen & Global Pharmaceutical Manufacturers Discuss “Moving Health Forward” at Second Annual ThinkLive Trade Virtual Conference
AmerisourceBergen concluded its second annual ThinkLive Trade virtual event, a three-day online summit geared toward brand, specialty, generic and consumer-product manufacturers.
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2021 on Thursday, November 4, 2021, prior to the opening of trading on the New York Stock Exchange.
Teva Pharmaceuticals reached a $15 million agreement with the state of Louisiana to settle claims against the company over its marketing of opioid products.
AmerisourceBergen Corporation announced that it will participate virtually in the following upcoming investor conferences.
AmerisourceBergen, a global healthcare company, bolstered its suite of manufacturer solutions through the addition of FirstView Financial.
AmerisourceBergen announced the appointment of Elizabeth Campbell as Executive Vice President and Chief Legal Officer.
AmerisourceBergen Corporation reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent year-over-year to $53.4 billion.
Sponsored | The essential guide to drug commercialization: A manufacturer’s handbook for selectin...
7/30/2021Learn how to unlock product potential in this step-by-step guide to making the most of your commercialization investments.
Total payment amounts are contingent on the number of governments that will agree to suspend their lawsuits as part of the deal.
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate virtually in the following upcoming investor conferences: Goldman Sachs 42nd Annual Global Healthcare Conference, to be held on June 8-11, 2021; and Baird Healthcare ESG Symposium, to be held on June 17, 2021.
AmerisourceBergen Corporation announced the completion of its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses for $6.275 billion in cash, subject to a customary working capital and net debt adjustment, and 2 million shares of AmerisourceBergen common stock.
Anivive Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Newest Lymphoma Treatment for Dogs
Strategic collaboration ensures veterinarians have rapid, easy access to LAVERDIA™-CA1 (verdinexor), the first oral tablet conditionally approved by the U.S. Food and Drug Administration (FDA) to treat lymphoma in dogs
Good Neighbor Pharmacy Surpasses 1 Million Doses of COVID-19 Vaccines Allocated through Federal Retail Pharmacy Program, Launches COVID-19 Vaccines Locator Tool
Good Neighbor Pharmacy, AmerisourceBergen’s network of independent community pharmacies, launched a COVID-19 Vaccines Pharmacy Locator Tool on MyGNP.com, a web-based platform designed to conveniently connect individuals with their local community pharmacy to receive COVID-19 vaccines.
AmerisourceBergen Corporation reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent year-over-year to $49.2 billion.
Theranos founder Elizabeth Holmes is back in the courtroom for the first time in 15 months for a three-day hearing ahead of her criminal fraud trial.
AmerisourceBergen Foundation Donates $700,000 to Boys & Girls Clubs of America to Roll Out COVID-19 Vaccine Education Programs Across the U.S.
The AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization focused on supporting health-related causes that enrich the global community, announced today a $700,000 donation to Boys & Girls Clubs of America to support COVID-19 vaccine education and awareness in an effort to remove barriers to vital healthcare access.